Share
Khush F. Mehta
Brainomix, a leading MedTech company specializing in AI-powered imaging solutions for stroke and lung fibrosis, has appointed Khush F. Mehta as Chair of the Board of Directors, marking a significant milestone in its global growth journey.
Mehta succeeds Professor Jacqueline “Jackie” Hunter, CBE, who has served as Chair for the past five years, guiding Brainomix through a critical phase of expansion and innovation.
Mehta brings over two decades of international leadership in healthcare, with deep expertise in artificial intelligence and medical imaging. His appointment comes at a pivotal time for Brainomix, as the company accelerates the commercial rollout of its flagship Brainomix 360 platform, following its recent £14 million ($18 million) Series C funding round and FDA clearance for a groundbreaking, patented diagnostic feature.
Previously, Mehta served as Chairman of Arterys, a pioneer in AI-driven radiology solutions, which was acquired by Tempus AI in 2022. Earlier in his career, he held senior executive roles at Siemens Healthcare, including Chief Strategy Officer and regional leadership positions across Asia Pacific, the US, and Germany, where he was instrumental in driving operational performance and market expansion.
Mehta holds an MBA from Yale School of Management and a Master’s in Commerce and Financial Management from Sydenham College. Based in the United States, he will play a key role in supporting Brainomix’s internationalization strategy, with a strong emphasis on scaling operations in North America, a priority market for the company.
His appointment also coincides with the retirement of Andrew Barker, Brainomix’s first Chair and Founding Director, whose early leadership helped transform the company from a University of Oxford spin-out into a recognized innovator in global medical AI.
With Mehta at the helm of its Board, Brainomix strengthens its governance and global outlook, reaffirming its mission to revolutionize diagnostic pathways and improve patient outcomes through AI-enabled medical imaging.
